A multiplex fluorescence quantitative PCR kit for detecting monkeypox virus and its subtypes

Through the development of a one-step multi-fluorescent quantitative PCR kit, the problems of high detection cost and difficulty in identifying subtypes in the existing technology have been solved, and the rapid, economical and efficient detection of monkeypox virus and its subtypes have been achieved. Rapid screening and epidemiological research on monkeypox virus.

CN115466800BActive Publication Date: 2024-11-08THE FIRST AFFILIATED HOSPITAL ZHEJIANG UNIV COLLEGE OF MEDICINE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210699066.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-06-20
Publication Date
2024-11-08
Estimated Expiration
2042-06-20

AI Technical Summary

Technical Problem

The existing monkeypox virus detection mainly relies on single-weight real-time fluorescence PCR technology, which requires more costs and is inconvenient to identify its subtypes. The gene sequencing technology is complex and costly, which affects the rapid detection of monkeypox virus and its subtypes. and epidemiological research.

Method used

A one-step multi-fluorescent quantitative PCR kit has been developed, including quantitative PCR reaction solution, enzyme mixture, primer and probe mixture, standards and reference samples. It uses specific primers and fluorescently labeled probes to be able to be used in one reaction Monkeypox virus and its subtypes (monkeypox-West African strain and monkeypox-Congo Basin strain) and the internal reference gene RNase P are simultaneously detected in the tube to simplify the detection process and improve the detection efficiency.

Benefits of technology

It realizes rapid, simple, economical, highly sensitive and specific detection of monkeypox virus and its subtype, reduces detection costs, and judges the nucleic acid quality of the sample through internal reference, improves the reliability of the detection results, and is suitable for monkeys. Rapid screening and epidemiological studies of poxvirus.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115466800B_ABST
    Figure CN115466800B_ABST
Patent Text Reader

Abstract

The present invention provides a multiplex fluorescence quantitative PCR kit for detecting monkeypox virus and its subtypes, wherein the monkeypox virus includes monkeypox virus, monkeypox-West African strain, and monkeypox-Congo Basin strain and RNase P and its subtypes. The present invention respectively designs highly specific primer probes according to the highly conserved nucleotide sequences of monkeypox virus, so that the presence of monkeypox virus and its subtypes (monkeypox-West African strain and monkeypox-Congo Basin strain) can be detected from blood / secretory samples simultaneously by a PCR reaction, which is simpler, faster, and has lower cost than the single fluorescence quantitative PCR method, and has better sensitivity, specificity and repeatability. The virus to be tested is fully enclosed for detection and single-tube amplification for real-time quantification, and monkeypox virus and its subtypes can be effectively and quickly screened according to the number of copies of viral infection. The present invention can be applied to the rapid screening and identification of monkeypox virus and its subtypes and the epidemiological study of monkeypox virus.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology and relates to a fluorescence quantitative PCR detection kit, in particular to a multiplex fluorescence quantitative PCR kit for detecting infectious viruses. The invention is a one-step multiplex real-time fluorescence quantitative PCR nucleic acid detection technology for detecting monkeypox virus and its subtypes (monkeypox-West African strain and monkeypox-Congo Basin strain) in blood / secretory specimens in the same reaction tube, and can be applied to the rapid screening of monkeypox virus and its subtypes and epidemiological research of monkeypox virus. Background Art

[0002] Monkeypox is a rare zoonosis characterized by skin rash. It is an infectious disease caused by the monkeypox virus, which belongs to the Poxviridae family and is in the same genus as the smallpox virus. The clinical symptoms and histopathology of monkeys and humans infected with the monkeypox virus are difficult to distinguish from smallpox infection. In addition, the monkeypox virus and the smallpox virus have common antigens, and there is a strong serological cross-reaction and cross-immunity between the two. In 1958, the monkeypox virus was isolated from laboratory monkeys, and later in other animals in Africa (such as squirrels, rats, mice, rabbits, porcupines and pangolins). In 1970, the first case of monkeypox virus infection was confirmed in a 9-month-old African boy. Since then, the monkeypox virus has gradually spread to other African countries, mainly in Central Africa and West Africa. For decades, the virus has been spreading and causing death in Africa. Since 2003, monkeypox infection has been found in many countries around the world, and most of the infected people have been in contact with sick animals. Especially since June 2021, the monkeypox virus has shown a trend of global spread, and the number of infections and deaths has increased abnormally. With the rapid spread of monkeypox cases, the World Health Organization (WHO) held an emergency meeting on monkeypox on May 20, 2022. Since the beginning of this year, 1,536 suspected cases have been reported in eight countries in the WHO African region, of which 59 have been confirmed and 72 have died. As of June 8, the WHO report showed that 28 countries around the world have reported 1,285 laboratory-confirmed cases and 1 suspected case. Common typical symptoms of monkeypox virus include fever, swollen lymph nodes, and then a rash concentrated on the face and limbs. Monkeypox virus is mainly transmitted through close contact between humans and infected animals, and the main mode of transmission of monkeypox virus is "close contact between people", but it is not clear whether the virus can be transmitted through aerosols. Genome sequencing analysis of viral DNA shows that monkeypox virus mainly includes two subtypes (monkeypox virus type I and monkeypox virus type II), and the current prevalent one is the monkeypox-West African strain. For the prevention and control of monkeypox virus, WHO is currently developing or partially developing interim guidelines to support member states in raising awareness, surveillance, laboratory diagnosis and testing, case investigation and contact tracing, clinical management and infection prevention and control, vaccines and immunization, as well as risk communication and community participation. Timely and accurate laboratory confirmation of monkeypox virus is the key to breaking the chain of transmission and preventing the outbreak. Currently, the main application for monkeypox virus detection is real-time / conventional polymerase chain reaction (PCR) technology based on nucleic acid amplification technology (NAAT), and gene sequencing technology can also be used. Laboratory confirmation samples are exudates from the surface of the rash, and blood and secretions are also important supplements. The current PCR technology for detecting monkeypox mainly uses single-plex real-time fluorescence PCR technology, so the establishment of a one-step multiplex real-time fluorescence PCR technology to detect and identify monkeypox virus and its subtypes is crucial for the prevention and control of the epidemic.

[0003] At present, the detection of monkeypox virus and its subtypes (monkeypox-West African strain and monkeypox-Congo Basin strain) at home and abroad mainly adopts single nucleic acid detection or gene sequencing technology. Gene sequencing technology requires professional personnel, and factors such as expensive detection costs and long operation time seriously affect the widespread application of this technology. Although single real-time fluorescence PCR technology can quickly detect monkey viruses, it requires more costs to identify its subtypes (monkeypox-West African strain and monkeypox-Congo Basin strain). Multiplex real-time fluorescence quantitative PCR technology has the advantages of fully enclosed detection, single-tube amplification real-time quantification, simplicity and speed, cost saving, good repeatability, and high specificity and sensitivity. It is more optimized than ordinary and single PCR detection, and can be used as a rapid and effective detection method for monkeypox virus and its subtypes (monkeypox-West African strain and monkeypox-Congo Basin strain). Summary of the invention

[0004] The purpose of the present invention is to provide a multiplex fluorescence quantitative PCR kit for detecting monkeypox virus and its subtypes, which is a one-step multiplex fluorescence quantitative PCR kit for detecting monkeypox virus (hMPV), monkeypox-West African subtype (hMPV / WA), monkeypox-Congo Basin subtype (hMPV / CB) and RNase P. The kit comprises a quantitative PCR reaction solution, an enzyme mixture, a primer and probe mixture, a standard (a plasmid of hMPV, hMPV / WA, hMPV / CB and RNase P at an appropriate concentration), a positive control (a plasmid of hMPV, hMPV / WA, hMPV / CB and RNase P at an appropriate concentration), and a negative control. The box body is provided with container holes, which are respectively placed with a quantitative PCR reaction solution tube, an enzyme mixture tube, a primer and probe mixture tube, a standard tube (hMPV, hMPV / WA, hMPV / CB and RNase P plasmid), a positive control tube (hMPV, hMPV / WA, hMPV / CB and RNase P), and a negative control tube.

[0005] The quantitative PCR reaction solution tube includes a PCR reaction buffer tube (containing magnesium chloride and a mixture of deoxyribonucleotide triphosphates, etc.), an enzyme mixture tube (containing heat-resistant Taq DNA polymerase and heat-resistant RNaseH, etc.). The primer and probe mixture tube contains four sets of primers and four corresponding probes with different fluorescent labels, and the primer and probe mixture tube is a brown tube. The negative control is high temperature and high pressure sterilized DEPC (diethyl pyrocarbonate) treated water, and the positive control is a positive plasmid sample of hMPV, hMPV / WA, hMPV / CB and RNase P.

[0006] The upstream primer and downstream primer and the corresponding specific probe sequences used in the one-step multiplex fluorescence quantitative PCR detection are as follows: Upstream primer hMPV-F: 5'-GTCAGCAGTGGCGATTTTCT-3'

[0007] Downstream primer hMPV-R: 5'-TGAACCAGATGGTCCTCTCAATA-3'

[0008] Specific probe hMPV-P: 5'-FAM-TAATAAACACCCACGTAAATACAAAACAGA-BHQ1-3'

[0009] Upstream primer hMPV / WA-F: 5'-ATATCACTACGGACATAAACCATTGT-3'

[0010] Downstream primer hMPV / WA-R: 5-ACGTCGATGTCAGAAATAATCAAC-3'

[0011] Specific probe hMPV / WA-P: 5'-ROX-TAAGTTCCTGGATCGGATGTCACCGC-BHQ2-3'

[0012] Upstream primer hMPV / CB-F: 5'-GATATAGGTGTCTTCATAACGCATT-3'

[0013] Downstream primer hMPV / CB-R: 5'-GCGTGAATATCTAAAGATTATGGG-3'

[0014] Specific probe hMPV / CB-P: 5'-CY5-TCTCAAATACATGATAGGATAATAGAATGCTAA-BHQ3-3' Upstream primer RNase PF: 5'-AGATTTGGACCTGCGAGCG-3'

[0015] Downstream primer RNase PR: 5'-GAGCGGCTGTCTCCACAAGT-3'

[0016] Specific probe RNase PP: 5'-VIC-TTCTGACCTGAAGGCTCTGCGCG-BHQ1-3'.

[0017] The specific probes for monkeypox virus, monkeypox-West African strain, monkeypox-Congo Basin strain and RNase P were labeled with four different fluorescent markers, FAM, ROX, CY5 and VIC, respectively, and the primers and probes were synthesized by Zhuhai Huirui Biotechnology Co., Ltd.

[0018] The above standards include monkeypox virus, monkeypox-West African strain, monkeypox-Congo Basin strain and RNase P standard, and the gene sequences of the conserved regions are as follows:

[0019] The sequence of the monkeypox virus standard is:

[0020] ATATTTGGTATTACCACATTAATTATATTGTCAGCAGTGGCGATTTTCTGTATTACGTATTATATATGTAATAAACACCCACGTAAATACAAACAGAGAACAAAGTCTAGATTTTGACTTACATAAATATCTGGGATAATAAAATCTATCATATTGAGAGGACCATCTGGTTCAGGAAAGACAGCCATAACCAAAAGA.

[0021] The sequence of the monkeypox-West African strain standard is:

[0022] GATTAAATATTTTAATAGTATCCATTTTATATCACTACGGACATAAACATTGTATATTTTTTATGTTTATTAGTGTACACATTTTGGAAGTAAGTTCCTGGATCGGATGTCACCGCAGTAATAATGTTGATTATTTCTGACATCGACGTATTATATAGTTTTTTAATTCCATATCTTT.

[0023] The sequence of the monkeypox-Congo Basin strain standard is:

[0024] CTTGATACTTTTTCTAGAAAAAAAATTGAATTGATGATATAGGTGTCTTCATAACGCATTATTACGTTAGCATTCTATTATCCTATCATGTATTTGAGAGTCTTATATGTAGCAAACATGATAACTGCAATACCCATAATCTTTAGATATTCACGCGTGCTATGGATGGCATTATCCCGCGGT.

[0025] The sequence of the RNase P standard is:

[0026] ATGGGACTTCAGCATGGCGGTGTTTGCAGATTTGGACCTGCGAGCGGGTTCTGACCTGAAGGCTCTGCGCGGACTTGTGGAGACAGCCGCTCACCTTGGCTATTCAGTTGTTGCTATC.

[0027] The kit provided by the present invention needs to be stored at -20°C, and the number of repeated freezing and thawing is reduced; the primer and probe mixture is stored in the dark.

[0028] Another object of the present invention is to provide the multiplex fluorescence quantitative PCR detection kit for use in the nucleic acid detection of monkeypox virus, monkeypox-West African strain and monkeypox-Congo Basin strain, as well as the determination of sample collection status and nucleic acid extraction status.

[0029] Method of using the kit of the present invention: positive control and negative control should be set in each fluorescence quantitative detection. The standard product is diluted to 1×10 2 -1×10 8 copies / mL.

[0030] Extraction of sample nucleic acid: 200uL serum sample was taken for extraction. Nucleic acid extraction was performed using ViralNucleic Acid extraction Kit II from Geneaid Company, and the extraction operation was performed according to the instructions in the kit. 10uL of the final product sample nucleic acid was taken as the subsequent template.

[0031] Detection of nucleic acid: Take 10uL of the extracted nucleic acid of the sample to be tested as a template. The total reaction volume is 20uL, of which the fluorescent quantitative PCR reaction solution and Taq enzyme mixture are 10μL, the primer and probe mixture (20μmol / L, including four sets of primers and fluorescent probes) is 3μL, the template is 5μL, and the remaining water is added to the final volume of 20μL. Detection is performed on the ABI 7500 fluorescent quantitative PCR instrument. The reaction procedure is: pre-denaturation at 95℃, 5min; then denaturation at 95℃ for 10s, annealing and extension at 58℃ for 30s, multiple fluorescence detection at 58℃, and a total of 45 cycles.

[0032] Experimental result judgment: ① The sample collection is qualified. The CT values ​​of RNase P, monkeypox virus, monkeypox-West African strain and monkeypox-Congo Basin strain detected correspond to the corresponding fluorescent labeled probes. The sample collection is qualified and the nucleic acid extraction is successful. T If the value is <37, the result is positive; the rest of the test samples C T When the value is ≥40 or undetermined, the report is negative. ② Detection of C of monkeypox virus, monkeypox-West African strain and monkeypox-Congo Basin strain in the sample T When the value is ≤40 and the amplification curve is good, it is reported as positive. ③ Test sample C T Value 37 ≤ C T For samples with a value <40, it is recommended to retest, and the retest result is 37≤C T If the value is <40 and the amplification curve is good, it is reported as positive for the corresponding virus according to the judgment criteria of ②. According to the obtained standard curve, the virus copy number (copies / mL) of monkeypox virus, monkeypox-West African strain and monkeypox-Congo Basin strain in the test specimen is calculated.

[0033] This study designed specific primers and probes for monkeypox virus, monkeypox-West African strain and monkeypox-Congo Basin strain; and used RNase P as an internal reference. The single-tube one-step multiplex real-time fluorescence quantitative PCR can detect monkeypox virus, monkeypox-West African strain and monkeypox-Congo Basin strain in a single tube, which not only significantly reduces the detection cost, but also obtains rich detection information. The introduction of internal reference can determine the quality of sample nucleic acid and assist in the judgment of test results. In addition, multiplex real-time fluorescence quantitative PCR also has extremely high sensitivity and specificity.

[0034] The invention is beneficial in that it adopts a one-step real-time fluorescence quantitative PCR technology with high specificity and high sensitivity, designs highly specific primers and fluorescently labeled probes for monkeypox virus and its subtypes (monkeypox-West African strain and monkeypox-Congo Basin strain), introduces a conservative internal reference gene RNase P, and develops a multiplex fluorescence quantitative PCR detection kit for detecting monkeypox virus and its subtypes (monkeypox-West African strain and monkeypox-Congo Basin strain) and determining sample collection and nucleic acid extraction. The invention can simultaneously detect whether monkeypox virus and its subtypes (monkeypox-West African strain and monkeypox-Congo Basin strain) are present in blood / secretory samples through a PCR reaction, which is simpler, faster, more cost-effective, and has better sensitivity, specificity and repeatability than the single-plex fluorescence quantitative PCR method. The virus to be tested is subjected to fully enclosed single-tube amplification real-time quantitative detection, and monkeypox virus and its subtype viruses can be effectively and quickly screened according to the number of copies of the virus infection. This technology can be applied to the rapid screening and identification of monkeypox virus and its subtypes (monkeypox-West African strain and monkeypox-Congo Basin strain) and the study of monkeypox virus epidemiology. BRIEF DESCRIPTION OF THE DRAWINGS

[0035] Figure 1 Schematic diagram of the structure of this kit.

[0036] Figure 2 This is an example of using this kit to detect monkeypox virus positive plasmid.

[0037] Figure 3 This is an example of using this kit to detect positive plasmids of Monkeypox-West African strain.

[0038] Figure 4 This is an example of using this kit to detect positive plasmids of Monkeypox-Congo Basin strain.

[0039] Figure 5 The sensitivity of this kit for detecting monkeypox virus is 10 from left to right (1-7). 8 , 10 7 , 10 6 , 10 5 ,

[0040] 10 4, 10 3 , 10 2 copies / mL.

[0041] Figure 6 This is the real-time fluorescence quantitative PCR standard curve of the monkeypox virus standard in this kit.

[0042] Figure 7 The sensitivity of this kit for detecting monkeypox-West African strain is 10 from left to right (1-7). 8 , 10 7 , 10 6 , 10 5 ,

[0043] 10 4 , 10 3 , 10 2 copies / mL.

[0044] Figure 8 This is the real-time fluorescence quantitative PCR standard curve of the monkeypox-West African strain standard in this kit.

[0045] Fig. 9 The sensitivity of this kit for detecting monkeypox-Congo Basin strain is 10 from left to right (1-7). 8 , 10 7 , 10 6 , 10 5 , 10 4 , 10 3 , 10 2 copies / mL.

[0046] Fig.10 This is the real-time fluorescence quantitative PCR standard curve of the monkeypox-Congo Basin strain standard in this kit.

[0047] Fig.11 This is the sensitivity of this kit to detect RNase P, from left to right (1-7) is 10 8 , 10 7 , 10 6 , 10 5 , 10 4 , 10 3 , 10 2 copies / mL.

[0048] Fig.12 This is the standard curve of real-time fluorescence quantitative PCR for the RNase P standard of this kit.

[0049] Fig.13 This is the result of mixed detection of positive plasmids of monkeypox virus and its subtypes (monkeypox-West African strain and monkeypox-Congo Basin strain). DETAILED DESCRIPTION

[0050] The present invention will be further described below in conjunction with the accompanying drawings and specific embodiments. The following embodiments are only intended to illustrate the present invention but not to limit the scope of the present invention.

[0051] Example 1

[0052] A multiplex fluorescence quantitative PCR detection kit for monkeypox virus and its subtypes (monkeypox-West African strain and monkeypox-Congo Basin strain), the kit comprising a quantitative PCR reaction solution and an enzyme mixture, a primer and a probe mixture, a standard product (monkeypox virus, monkeypox-West African strain, monkeypox-Congo Basin strain, RNase P), a positive control product (monkeypox virus, monkeypox-West African strain, monkeypox-Congo Basin strain, RNase P), and a negative control product. The box body is provided with container holes, which are respectively placed with a quantitative PCR reaction solution tube, an enzyme mixture tube, a primer and a probe mixture tube, a standard product tube (monkeypox virus, monkeypox-West African strain, monkeypox-Congo Basin strain, RNase P), a positive control product tube (monkeypox virus, monkeypox-West African strain, monkeypox-Congo Basin strain, RNase P), and a negative control product tube.

[0053] See also Figure 1 , the container hole is provided in the package of this kit for placing the corresponding kit components: quantitative PCR reaction solution tube and enzyme mixture tube 1 (quantitative PCR reaction solution and enzyme mixture), primer and probe mixture tube 2, negative control tube 3, standard tube (including monkeypox virus standard 4-1, monkeypox-West African strain standard 4-2, monkeypox-Congo Basin strain standard 4-3, RNase P standard 4-4, a total of 4 tubes), positive control tube (including monkeypox virus positive control 5-1, monkeypox-West African strain positive control 5-2, monkeypox-Congo Basin strain positive control 5-3, RNase P positive control 5-4, a total of 4 tubes). The kit contains: quantitative PCR reaction solution and enzyme mixture, primer and probe mixture, standard (monkeypox virus, monkeypox-West African strain, monkeypox-Congo Basin strain, RNase P), positive control (monkeypox virus, monkeypox-West African strain, monkeypox-Congo Basin strain, RNase P), negative control.

[0054] Example 2

[0055] 1 Materials and methods

[0056] 1.1 Plasmid samples:

[0057] The positive plasmids of monkeypox virus and its subtypes (monkeypox-West African strain, monkeypox-Congo Basin strain) were donated free of charge by Zhuhai Huirui Biotechnology Co., Ltd.

[0058] In addition, other herpes virus-positive specimens such as enterovirus 71 (EV71), herpes simplex virus (HSV), Epstein-Barr virus (EBV), and cytomegalovirus (CMV) were provided by the State Key Laboratory of Diagnosis and Treatment of Infectious Diseases and our laboratory.

[0059] 1.2 Primers and probes

[0060] Multiple gene sequences of monkeypox virus and its subtypes (monkeypox-West African strain, monkeypox-Congo Basin strain) from home and abroad were downloaded from the NCBI gene library. DNAman software was used to compare the homology and determine the conserved regions of the above viral genomes. Primer Express 3.0 software was used to design highly specific primers and TaqMan probes in its conserved regions. Both primer and probe sequences were verified by Blast and had good specificity.

[0061] The primer and probe sequences are as follows:

[0062] Upstream primer hMPV-F: 5'-GTCAGCAGTGGCGATTTTCT-3'

[0063] Downstream primer hMPV-R: 5'-TGAACCAGATGGTCCTCTCAATA-3'

[0064] Specific probe hMPV-P: 5'-FAM-TAATAAACACCCACGTAAATACAAAACAGA-BHQ1-3'

[0065] Upstream primer hMPV / WA-F: 5'-ATATCACTACGGACATAAACCATTGT-3'

[0066] Downstream primer hMPV / WA-R: 5-ACGTCGATGTCAGAAATAATCAAC-3'

[0067] Specific probe hMPV / WA-P: 5'-ROX-TAAGTTCCTGGATCGGATGTCACCGC-BHQ2-3'

[0068] Upstream primer hMPV / CB-F: 5'-GATATAGGTGTCTTCATAACGCATT-3'

[0069] Downstream primer hMPV / CB-R: 5'-GCGTGAATATCTAAAGATTATGGG-3'

[0070] Specific probe hMPV / CB-P: 5'-CY5-TCTCAAATACATGATAGGATAATAGAATGCTAA-BHQ3-3' Upstream primer RNase PF: 5'-AGATTTGGACCTGCGAGCG-3'

[0071] Downstream primer RNase PR: 5'-GAGCGGCTGTCTCCACAAGT-3'

[0072] Specific probe RNase PP: 5'-VIC-TTCTGACCTGAAGGCTCTGCGCG-BHQ1-3'.

[0073] The primer and probe sequences of RNase P were cited from J Clin Microbiol. 2005Apr; 43(4): 1851–1857. The above primers and probes were commissioned to Zhuhai Huirui Biotechnology Co., Ltd. for synthesis.

[0074] 1.3 Extraction of viral nucleic acid and quantitative standards of standard products:

[0075] Extraction of sample nucleic acid: 200uL serum sample was drawn into EP tube for nucleic acid extraction. Nucleic acid extraction was performed using Viral Nucleic Acid extraction Kit II from Geneaid Company according to the instructions of the kit, and 10uL of the extracted nucleic acid of the sample to be tested was taken as a template.

[0076] Synthesize each gene standard fragment and connect it to the plasmid vector pMDTM19-T Simple Vector (TaKaRa). Culture after transformation. Extract plasmid DNA after identification, measure the plasmid DNA concentration using NanoDrop ND-2000 Spectrophotometer, determine the DNA copy number, and use it as the standard quantitative mother solution. According to the experimental needs, dilute the standard quantitative mother solution to the required maximum concentration, and dilute it tenfold to the minimum concentration, and store it at -20℃ for future use.

[0077] 1.4 Optimization of multiplex real-time fluorescence quantitative PCR reaction system and conditions:

[0078] Detection of nucleic acid: Take 5uL of the extracted nucleic acid of the sample to be tested as a template. The total reaction volume is 20μL, of which the fluorescent quantitative PCR reaction solution and Taq enzyme mixture are 10μL, the primer and probe mixture (20μmol / L, including four sets of primers and fluorescent probes) is 3μL, the template is 5μL, and the remaining water is added to the final volume of 20μL. Detection is performed on the ABI 7500 fluorescent quantitative PCR instrument. The reaction procedure is: pre-denaturation at 95℃, 5min; then denaturation at 95℃ for 10s, annealing and extension at 58℃ for 30s, multiple fluorescence detection at 58℃, and a total of 45 cycles.

[0079] Result judgment: Select the fluorescence detection channels FAM, ROX, CY5, and VIC, select the average value of the fluorescence signal of 3-15 cycles for the fluorescence baseline, and set the threshold so that the threshold line just exceeds the highest point of the negative control. ① Sample collection qualified monkeypox virus and its subtypes (monkeypox-West African strain, monkeypox-Congo Basin strain) detection of each C T The value corresponds to the corresponding fluorescently labeled probe. If the sample collection is qualified and the nucleic acid extraction is successful, the RNase P test is positive; when the sample C T When the value is ≥40, 0 or no value, it is reported as negative. ② When detecting C of positive plasmid / sample of monkeypox virus and its subtypes (monkeypox-West African strain, monkeypox-Congo Basin strain) T When the value is <37, it is reported as positive. T For samples with a value ≥ 37 and less than 40, retesting is recommended. The retest result is C T If the value is ≥37 and less than 40, it is reported as positive for the corresponding virus according to the judgment criteria of ②. In the optimization test of the system, in the reaction system with the same concentration of positive nucleic acid as the template, the matrix method is used to screen the most suitable concentrations of primers and probes. The primer concentration ranges from 1 to 20 μM, and the probe concentration ranges from 1 to 20 μM. The most suitable primer and probe concentrations are selected according to the lowest Ct value and the highest fluorescence intensity increase value (ΔRn).

[0080] 1.5 Multiplex real-time fluorescence quantitative PCR specificity, sensitivity and repeatability test

[0081] We selected monkeypox virus and its subtypes (monkeypox-West African strain, monkeypox-Congo Basin strain) positive specimens (all from monkeypox virus, monkeypox-West African strain, monkeypox-Congo Basin strain positive plasmids) and other herpes viruses such as EV71, HSV, EBV and CMV positive clinical specimens. Unfortunately, there are no clinical specimens positive for poxvirus and its subtypes in China. We used multiplex real-time fluorescence quantitative PCR to verify the specificity of the method. We used a synthetic fragment of monkeypox virus (10 copies / mL) with a calibrated copy number (copies / mL) to detect the specificity of the method. 8 copies / ml), monkeypox-West African strain synthetic fragment (10 8copies / ml), monkeypox-Congo Basin strain synthetic fragment (10 8 copies / ml) and RNase P synthetic fragments (10 8 After diluting the samples at 1000 copies / ml, the fluorescence quantitative PCR reaction was performed in parallel to verify the sensitivity of the method. In addition, the positive standard sample of each specified concentration was tested three times, and the C T The standard deviation and coefficient of variation were calculated to verify the repeatability of the method.

[0082] 2 Results

[0083] 2.1 Multiplex real-time fluorescence quantitative PCR reaction system and conditions

[0084] Detection of nucleic acid: Take 5uL of the extracted nucleic acid of the sample to be tested as a template. The total reaction volume is 20μl, including 10μL of quantitative PCR reaction solution and enzyme mixture, 3μL of primer and probe mixture (20μmol / L, including four sets of specific primers and corresponding four fluorescent probes), 5μL of template, and add water to make up to 20μL. Detection is performed on an ABI 7500 fluorescent quantitative PCR instrument (or other PCR instruments with four-color fluorescence and above), and the reaction parameters are: the reaction program is: pre-denaturation at 95℃, 5min; then denaturation at 95℃ for 10s, annealing and extension at 58℃ for 30s, multiple fluorescence detection at 58℃, and a total of 45 cycles.

[0085] 2.2 Specificity test

[0086] The one-step multiplex fluorescence quantitative PCR method established by the present invention has good specificity for monkeypox virus and its subtypes (monkeypox-West African strain, monkeypox-Congo Basin strain), and can completely detect positive plasmid specimens. Unfortunately, there are no positive clinical samples in China for the time being. The multiplex primers and probes in the present invention have no cross-reaction with other and other herpes viruses such as EV71, HSV, EBV and CMV positive specimens. This method can specifically detect monkeypox virus and its subtypes (monkeypox-West African strain, monkeypox-Congo Basin strain) in plasmid specimens. The results are shown in Figure 2 , Figure 3 , Figure 4 and Fig.13 .

[0087] 2.3 Sensitivity test

[0088] The sensitivity of monkeypox virus and its subtypes (monkeypox-West African strain, monkeypox-Congo Basin strain) and RNase P were tested. The synthetic fragments of monkeypox virus with the calibrated copy number (copies / mL) (10 8 copies / mL), monkeypox-West African strain synthetic fragment (10 8copies / mL), synthetic fragments of monkeypox-Congo Basin strain (10 8 copies / mL) and RNase P synthetic fragments (10 8 After ten-fold gradient dilution, the kit was used for detection. The test results showed that the detection sensitivity of this method reached 10 2 , 10 2 , 10 2 and 10 2 copies / ml. Results are shown in Figure 5 , Figure 7 , Fig. 9 , Fig.11 The mixed test of positive samples of monkeypox virus and its subtypes (monkeypox-West African strain, monkeypox-Congo Basin strain) showed that the virus and internal reference test results can achieve single-tube simultaneous detection and differentiation of the above viruses (see Fig.13 ).

[0089] 2.4 Repeatability test

[0090] Take monkeypox virus synthetic fragments (final concentration 10 6 copies / mL), monkeypox-West African strain synthetic fragment (10 6 copies / mL) monkeypox-Congo Basin strain synthetic fragment (10 6 copies / mL) and RNase P synthetic fragments (10 6 copies / mL), and diluted 10-fold to 10 5 with 10 4 , for 10 6 , 10 5 , 10 4 The samples were tested three times and their coefficient of variation and standard deviation were calculated. T The standard deviation of the values ​​was between 0.18 and 0.67, and the coefficient of variation was less than 2.50%, which showed good repeatability (the results are shown in Table 1).

[0091] Table 1 Repeatability test of multiplex real-time fluorescence quantitative PCR detection of synthetic nucleic acids

[0092]

[0093] Example 3

[0094] This kit was used to test clinical samples, which were mainly derived from 50 discarded samples of pathogen detection specimens from the fever clinic between April 2022 and June 2021. The collected clinical specimens were tested by multiple real-time fluorescence quantitative PCR in this method, and the results are as follows: A total of 50 specimens were tested in the fever clinic, and the test results of monkeypox virus and its subtypes (monkeypox-West African strain, monkeypox-Congo Basin strain) were all negative. The positive results of this kit were 100% consistent with the positive results of the commercial kit (Zhijiang Biology). Sequence Listing <110> The First Affiliated Hospital of Zhejiang University School of Medicine <120> A multiplex fluorescence quantitative PCR kit for detecting monkeypox virus and its subtypes <160> 12 <170> SIPOSequenceListing 1.0 <210> 1 <211> 20 <212> DNA <213> Artificial sequence (unknown) <400> 1 gtcagcagtg gcgattttct 20 <210> 2 <211> 20 <212> DNA <213> Artificial sequence (unknown) <400> 2 gtcagcagtg gcgattttct 20 <210> 3 <211> 30 <212> DNA <213> Artificial sequence (unknown) <400> 3 taataaacacccacgtaaatacaaaacaga 30 <210> 4 <211> 26 <212> DNA <213> Artificial sequence (unknown) <400> 4 atatcactac ggacataaac cattgt 26 <210> 5 <211> twenty four <212> DNA <213> Artificial sequence (unknown) <400> 5 acgtcgatgt cagaaataat caac 24 <210> 6 <211> 26 <212> DNA <213> Artificial sequence (unknown) <400> 6 taagttcctg gatcggatgt caccgc 26 <210> 7 <211> 25 <212> DNA <213> Artificial sequence (unknown) <400> 7 gatataggtg tcttcataac gcatt 25 <210> 8 <211> twenty four <212> DNA <213> Artificial sequence (unknown) <400> 8 gcgtgaatat ctaaagatta tggg 24 <210> 9 <211> 33 <212> DNA <213> Artificial sequence (unknown) <400> 9 tctcaaatac atgataggat aatagaatgc taa 33 <210> 10 <211> 19 <212> DNA <213> Artificial sequence (unknown) <400> 10 agatttggac ctgcgagcg 19 <210> 11 <211> 20 <212> DNA <213> Artificial sequence (unknown) <400> 11 gagcggctgt ctccacaagt 20 <210> 12 <211> 23 <212> DNA <213> Artificial Sequence (unknown) <400> 12 ttctgacctg aaggctctgc gcg 23

Claims

1. A multiplex fluorescence quantitative PCR kit for detecting monkeypox virus and its subtypes, characterized in that: The kit comprises a quantitative PCR reaction solution, an enzyme mixture, a primer and probe mixture, a standard, a positive control, and a negative control; wherein the quantitative PCR reaction solution comprises a PCR reaction buffer and an enzyme mixture, and the primer and probe mixture comprises four sets of primers and corresponding four different fluorescently labeled probes; the upstream primers and downstream primers of the monkeypox virus, monkeypox-West African strain, monkeypox-Congo Basin strain, and ribonuclease for fluorescent quantitative PCR detection and the corresponding specific probe sequences are as follows: Upstream primer MPXV-F: 5'- GTCAGCAGTGGCGATTTTCT-3' Downstream primer MPXV-R: 5'-TGAACCAGATGGTCCTCTCAATA-3' Specific probe MPXV-P: 5'-FAM-TAATAAACACCCACGTAAATACAAAACAGA-BHQ1-3' Upstream primer MPXV / WA-F: 5'-ATATCACTACGGACATAAACCATTGT-3' Downstream primer MPXV / WA-R: 5- ACGTCGATGTCAGAAATAATCAAC-3' Specific probe MPXV / WA-P: 5'-ROX-TAAGTTCCTGGATCGGATGTCACCGC-BHQ2-3' Upstream primer MPXV / CB-F: 5'- GATATAGGTGTCTTCATAACGCATT-3' Downstream primer MPXV / CB-R: 5'-GCGTGAATATCTAAAGATTATGGG-3' Specific probe MPXV / CB-P: 5'-CY5-TCTCAAATACATGATAGGATAATAGAATGCTAA-BHQ3-3' Upstream primer RNase PF: 5'-AGATTTGGACCTGCGAGCG-3' Downstream primer RNase PR: 5'-GAGCGGCTGTCTCCACAAGT-3' Specific probe RNase PP: 5'-VIC-TTCTGACCTGAAGGCTCTGCGCG-BHQ1-3' The standard includes plasmids of the conserved gene sequences of MPXV, MPXV / WA, MPXV / CB and RNase P: The gene sequence of the conserved region of the monkeypox virus standard is: ATATTTGGTATTACCACATTAATTATATTGTCAGCAGTGGCGATTTTCTGTATTACGTATTATATATGTAATAAACACCCACGTAAATACAAACAGAGAACAAAGTCTAGATTTTGACTTACATAAATATCTGGGATAATAAAATCTATCATATTGAGAGGACCATCTGGTTCAGGAAAGACAGCCATAACCAAAAGA The conserved gene sequence of the monkeypox-West African strain standard is: GATTAAATATTTTAATAGTATCCATTTTATATCACTACGGACATAAACATTGTATATTTTTTATGTTTATTAGTGTACACATTTTGGAAGTAAGTTCCTGGATCGGATGTCACCGCAGTAATAATGTTGATTATTTCTGACATCGACGTATTATATAGTTTTTTAATTCCATATCTTT The conserved gene sequence of the monkeypox-Congo Basin strain standard is: TCTTGATACTTTTTCTAGAAAAAAAATTGAATTGATGATATAGGTGTCTTCATAACGCATTATTACGTTAGCATTCTATTATCCTATCATGTATTTGAGAGTCTTATATGTAGCAAACATGATAACTGCAATACCCATAATCTTTAGATATTCACGCGTGCTATGGATGGCATTATCCCGCGGT The conserved gene sequence of the RNase P standard is: ATGGGACTTCAGCATGGCGGTGTTTGCAGATTTGGACCTGCGAGCGGGTTCTGACCTGAAGGCTCTGCGCGGACTTGTGGAGACAGCCGCTCACCTTGGCTATTCAGTTGTTGCTATC.

2. The kit according to claim 1, characterized in that The negative control was high temperature and high pressure sterilized diethyl pyrocarbonate treated water, and the positive control was monkeypox virus, monkeypox-West African strain, monkeypox-Congo Basin strain and RNase P positive plasmid samples.

3. The kit according to claim 1, characterized in that The PCR reaction buffer contains magnesium chloride and a mixture of deoxyribonucleotide triphosphates, and the enzyme mixture contains thermostable Taq DNA polymerase and thermostable RNaseH.

4. The kit according to claim 1, characterized in that The kit was stored at -20°C.